DRU Library Menu

This document provides a basic understanding of the drug evaluation and classification process.

Established in 1972, the NCJRS is a federally funded resource offering justice and drug-related information to support research, policy, and program development worldwide.

In the last several years, U.S. Law Enforcement has seen a dramatic increase in the availability of dangerous synthetic opioids. A large majority of these synthetic opioids are structural derivatives of the synthetic drug fentanyl. Fentanyl is a synthetic opioid currently listed as a Schedule II prescription drug that mimics the effects of morphine in the human body, but has potency 50-100 times… (read more)

These recommendations are the result of a Federal Interagency Working Group coordinated by the White House National Security Council. Stakeholder associations and organizations representing the medical, public health, law enforcement, Fire/EMS, and occupational safety and health disciplines provided invaluable input to inform the Interagency Working Group's efforts, and their feedback helped… (read more)

The Bureau of Justice Assistance's Law Enforcement Naloxone Toolkit is a clearinghouse of resources to support law enforcement agencies in establishing a naloxone program. The Law Enforcement Naloxone Toolkit was developed at the urging of the Attorney General in response to the growing opioid overdose epidemic. In the toolkit, you will find answers to frequent questions about naloxone and sample… (read more)

The International Drug Evaluation and Classification Program (DECP), coordinated by the International Association of Chiefs of Police (IACP) with support from the National Highway Traffic Safety Administration (NHTSA), trains law enforcement officers with the standardized Drug Recognition Expert (DRE) protocol and educates prosecutors and judges in the prosecution of drugged drivers.